This is a routine administrative filing correcting a missing Say-on-Pay proposal. No market-moving information. Monitor the June 26 meeting outcome for any unexpected opposition to director elections or compensation, though none are anticipated given management's unified recommendation.
VTVT drugs
VTVT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $31.59entry
- T+1 · 5mo ago +3.72%α +3.18% · $32.77
- T+5 · 5mo ago +7.38%α +6.94% · $33.92
- T+20 · 4mo ago +5.86%α +3.97% · $33.44
- T+60 · 2mo ago +5.57%α +1.18% · $33.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
vTv Therapeutics filed a DEFA14A to correct an inadvertent omission from its 2026 proxy statement, adding an advisory vote (Say-on-Pay) on executive compensation as Proposal 3. The annual meeting was adjourned from June 10 to June 26, 2026, without transacting any business, to allow shareholders time to review the new proposal. This is a routine administrative correction with no material financial or strategic impact.
Key Financial Metrics
Key Facts
- Original proxy statement (filed April 28, 2026) inadvertently omitted Proposal 3 for an advisory vote on executive compensation.
- Annual meeting convened June 10, 2026 was adjourned immediately without any business transacted.
- Adjourned meeting will resume June 26, 2026 at 11:00 AM ET via virtual webcast.
- Record date remains April 14, 2026; voting deadline extended to June 24, 2026.
- Board recommends FOR all three proposals: director election, auditor ratification, and Say-on-Pay.
- Proposal 1 (director election) and Proposal 3 (Say-on-Pay) are non-routine (broker discretionary voting prohibited).
Financial Impact
No financial figures disclosed; purely procedural proxy correction.
Risk Factors
- No material risks identified; routine filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-265834 |
| Document: 0001193125-26-265834-index-headers.html | 0001193125-26-265834 |
| Document: 0001193125-26-265834-index.html | 0001193125-26-265834 |
| Document: 0001193125-26-265834.txt | 0001193125-26-265834 |
Track record
9 reports on VTVT
Filters
- Nov 16, 2026today SC 13D/A Neutral 3/10 Entry $17.69 Now $17.69 +0.00% settles Dec 16
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $19.69 Now $17.69 −10.16% settles Dec 14
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $21.03 Now $17.69 −15.88% settles Dec 7
- Oct 8, 20265w ago SC 13G/A Neutral 3/10 Entry $31.18 to $21.03 Now $17.69 −43.26% ▼ −32.55% −26.99% vs SPY
- Jun 10, 202622w ago DEFA14A Neutral 3/10 Viewing Entry $31.59 to $33.44 Now $17.69 −44.00% ▲ +5.86% +3.97% vs SPY
- May 8, 202627w ago Press Release Neutral 2/10 Entry $30.46 to $31.77 Now $17.69 −41.92% ▲ +4.30% +4.61% vs SPY
- Mar 10, 202635w ago Press Release Mixed 6/10 Entry $35.10 to $37.30 Now $17.69 −49.60% ▲ +6.27% +5.74% vs SPY
- Feb 26, 202637w ago 8-K Neutral 4/10 Entry $39.32 to $37.80 Now $17.69 −55.01% ▼ −3.87% +2.54% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers